1-5 of 5 results for primarymember:"Pauline Latham"
Librarians' tools
- Search time
- 0.212 seconds
- Solr query time
- 0.002 seconds
- Search query
- primarymember:"Pauline Latham"
- We searched for
- primaryMember_ses:301778
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional variations in the provision of molecular radiotherapy.
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional variations in the provision of molecular radiotherapy.
Molecular radiotherapy is currently commissioned alongside brachytherapy via a national service specification. There are currently 38 trusts in England that are commissioned to deliver these services however, given the spectrum of treatments available under this service specification, there is some variation in what each provider offers.
For this reason, NHS England is developing a standalone molecular radiotherapy service specification. This will clarify the service model and review demand and access arrangements. The service specification will also take into account any future developments in treatment technologies and recommendations made by the National Institute for Health and Care Excellence.
Motion, That this House has considered patient pathways and research funding for aortic dissection. Agreed to on question.
Motion, That this House has considered patient pathways and research funding for aortic dissection. Agreed to on question.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) health outcomes and (b) early diagnosis for people with aortic dissections.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) health outcomes and (b) early diagnosis for people with aortic dissections.
In March 2022, NHS England launched an Aortic Dissection Toolkit to support the implementation of robust clinical pathways to identify and manage both Type A and Type B aortic dissection.
All English regions are working with the Cardiac Pathways Improvement Programme to improve diagnosis and treatment.
To ask the Secretary of State for Health and Social Care, for what reason the NHS is not using SureScreen CoVid-19 rapid antibody tests.
To ask the Secretary of State for Health and Social Care, for what reason the NHS is not using SureScreen CoVid-19 rapid antibody tests.
Local National Health Service trusts interested in securing serology or antibody tests are responsible for procuring those tests and deciding on the type of test kits. The Medicines and Health products Regulatory Agency is the national regulator for medical tests and any test can legally be marketed and deployed in the United Kingdom once it receives a CE mark.
The Government’s antibody testing programme continues to evolve in line with emerging needs, including to support ongoing research and surveillance studies.
What his timetable is for the reopening of adult day centres for people with learning difficulties after the covid-19 outbreak.
What his timetable is for the reopening of adult day centres for people with learning difficulties after the covid-19 outbreak.
I know how difficult it has been for people with learning disabilities and their families during lockdown, particularly without the back-up of day centres. I want to see those important services reopening as soon as it is possible and safe to do so, but that decision will need to be made locally. We are talking to the Local Government Association and others about what guidance and support may be needed to get day services up and running again.